Hyderabad, India, Feb. 05, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence, the tumor ablation market size is projected to expand from USD 1.94 billion in 2026 to USD 3.14 billion by 2031, registering a compound annual growth rate of 10.2% during the forecast period. Tumor ablation technologies are being widely used across hospitals and specialty cancer centers to treat solid tumors with greater precision, reduced recovery time, and lower procedural risk compared to conventional surgical approaches. The market’s growth is supported by rising global cancer incidence, increasing preference for image-guided interventions, and continuous innovation in ablation systems.
The tumor ablation industry is expanding as clinicians seek effective alternatives for patients who are not ideal candidates for open surgery. Techniques such as radiofrequency ablation, microwave ablation, cryoablation, and irreversible electroporation are increasingly integrated into oncology treatment protocols. These procedures enable targeted tumor destruction while preserving surrounding healthy tissue, supporting better clinical outcomes and improved patient quality of life.
Tumor Ablation Market Share by Region
- North America represents a significant tumor ablation market share, supported by advanced healthcare infrastructure, high adoption of minimally invasive procedures, and strong availability of skilled interventional radiologists and oncologists.
- Europe holds a substantial market share, driven by established cancer care networks, favorable reimbursement environments, and increasing emphasis on less invasive oncology treatments.
- Asia-Pacific is emerging as a high-growth region, supported by rising cancer burden, expanding hospital infrastructure, and improving access to advanced interventional oncology procedures across key markets.
Tumor Ablation Market Trends & Forecast
Rising Preference for Minimally Invasive Oncology Treatments
Healthcare providers are increasingly favoring tumor ablation procedures due to shorter hospital stays, reduced complication rates, and faster recovery times, making them suitable for a broader patient population.
Technological Advancements in Ablation Systems
Manufacturers are focusing on improving energy delivery precision, real-time monitoring, and device ergonomics. Integration of advanced imaging and navigation tools further enhances treatment accuracy and clinician confidence.
Tumor Ablation Market Segmentation Overview
By Technology
- Radiofrequency (RF) Ablation
- Microwave Ablation
- Cryoablation
- Irreversible Electroporation
- High-Intensity Focused Ultrasound (HIFU)
- Histotripsy
By Mode of Treatment
- Surgical Ablation
- Laparoscopic Ablation
- Percutaneous Ablation
- Robotic / Endoluminal Ablation
By Application
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Bone Metastasis
- Prostate Cancer
- Breast & Soft-Tissue Tumors
- Other Cancers (incl. Pancreas, Bladder, Brain)
End User
- Hospitals
- Cancer Centers
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Middle East & Africa
- South America
For a full breakdown of market dynamics, segmentation insights, regional analysis, and competitive landscape, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/tumor-ablation-market?utm_source=globenewswire
Tumor Ablation Market Competitive Outlook
The tumor ablation industry features a mix of established medical device companies and specialized interventional oncology solution providers. Market participants are focusing on product innovation, clinical validation, and strategic partnerships to expand their presence across oncology care settings and address evolving treatment needs.
Major Companies Include:
- Medtronic plc
- Johnson & Johnson (Ethicon)
- Boston Scientific Corp.
- AngioDynamics Inc.
- Siemens Healthineers
Check out related reports published by Mordor Intelligence
Radiofrequency Ablation Devices Market Size: The radiofrequency ablation devices market is estimated at USD 6.05 billion in 2026, rising to USD 10.63 billion by 2031, at a CAGR of 11.95% over the forecast period. Growth is supported by increasing adoption of minimally invasive procedures, rising incidence of cancer and chronic pain conditions, and expanding use of RF ablation in cardiology and oncology applications.
Trauma Fixation Devices Market Share: The trauma fixation devices market is projected to grow from USD 8.45 billion in 2026 to USD 11.55 billion by 2031, registering a CAGR of 6.43%. Market expansion is driven by a rising number of road accidents and sports injuries, growing geriatric population prone to fractures, and continued demand for advanced internal and external fixation systems.
Bariatric Surgery Devices Market Growth: The bariatric surgery devices market is expected to increase from USD 2.98 billion in 2026 to USD 3.85 billion by 2031, growing at a CAGR of 5.28% during the forecast period. Growth is fueled by the increasing prevalence of obesity and related comorbidities, wider acceptance of surgical weight-loss procedures, and ongoing improvements in minimally invasive bariatric technologies.
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
